Antibodies: An alternative for antibiotics?

Poultry Science

Volumn 84, Issue 4, 2005, Pages 660-666

  Berghman, L R ^a,b   Abi Ghanem, D ^a   Waghela, S D ^b   Ricke, S C ^a,b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Alternative; Antibiotic; Expression system; Plant; Recombinant antibody

Indexed keywords

ANIMALIA; GLYCINE MAX; ZEA MAYS;

EID: 18944392655     PISSN: 00325791     EISSN: None     Source Type: Journal    
DOI: 10.1093/ps/84.4.660     Document Type: Conference Paper

References (69)

1. Almeida, C. M., M. M. Kanashiro, F. B. Rangel Filho, M. F. Mata, T. L. Kipnis, and W. D. da Silva. 1998. Development of snake antivenom antibodies in chickens and their purification from yolk. Vet. Rec. 143:579-584.
2. Baldry, P. E. 1965. The Battle Against Bacteria: A History of the Development of Antibacterial Drugs for the General Reader. Cambridge University Press, Cambridge, UK.
3. Barrington, G. M., and S. M. Parish. 2001. Bovine neonatal immunology. Vet. Clin. North Am. Food Anim. Pract. 17:463-476.
4. Behring, E., and S. Kitasako. 1890. Ueber das Zustandekommen der Diphtherie-Immunität und der Tetanus-Immunität bei Thieren. Dtsch. Med. Wochenschr. 16:1113-1114.
5. Bird, R. E., K. D. Hardman, J. W. Jacobson, S. Johnson, B. M. Kaufman, S. M. Lee, T. Lee, S. H. Pope, G. S. Riordan, and M. Whitlow. 1988. Single-chain antigen-binding proteins. Science 242:423-426.
6. Buchwald, U. K., and L. Pirofski. 2003. Immune therapy for infectious diseases at the dawn of the 21st century: The past, present and future role of antibody therapy, therapeutic vaccination and biological response modifiers. Curr. Pharm. Des. 9:945-968.
7. Carlander, D., H. Kollberg, and A. Larsson. 2002. Retention of specific yolk IgY in the human oral cavity. BioDrugs 16:433-437.
8. Carlander, D., H. Kollberg, P. E. Wejaker, and A. Larsson. 2000. Peroral immunotherapy with yolk antibodies for the prevention and treatment of enteric infections. Immunol. Res. 21:1-6.
9. Carroll, S. B., B. S. Thalley, R. D. Theakston, and G. Laing. 1992. Comparison of the purity and efficacy of affinity purified avian antivenoms with commercial equine crotalid antivenoms. Toxicon 30:1017-1025.
10. Casadevall, A. 1996. Antibody-based therapies for emerging infectious diseases. Emerg. Infect. Dis. 2:200-208.
11. Casadevall, A., and M. D. Scharff. 1994. Serum therapy revisited: Animal models of infection and development of passive antibody therapy. Antimicrob. Agents Chemother. 38:1695-1702.
12. Casalvilla, R., M. Duenas, M. Ayala, S. Cruz, L. Cruz, W. A. Buurman, and J. V. Gavilondo. 1999. A bacterial single-chain Fv antibody fragment that inhibits binding of its parental anti-E-selectin monoclonal antibody to activated human endothelial cells. J. Biotechnol. 72:1-12.
13. Cirino, N. M., D. Sblattero, D. Allen, S. R. Peterson, J. D. Marks, P. J. Jackson, A. Bradbury, and B. E. Lehnert. 1999. Disruption of anthrax toxin binding with the use of human antibodies and competitive inhibitors. Infect. Immun. 67:2957-2963.
14. Conn, H. W., and H. J. Conn, ed. 1929. Bacteriology. Williams and Wilkins Co., Baltimore, MD.
15. Davidson, G. P., P. B. Whyte, E. Daniels, K. Franklin, H. Nunan, P. I. McCloud, A. G. Moore, and D. J. Moore. 1989. Passive immunisation of children with bovine colostrum containing antibodies to human rotavirus. Lancet 2:709-712.
16. De Jaeger, G., E. Buys, D. Eeckhout, C. De Wilde, A. Jacobs, J. Kapila, G. Angenon, M. Van Montagu, T. Gerats, and A. Depicker. 1999. High level accumulation of single-chain variable fragments in the cytosol of transgenic Petunia hybrida. Eur. J. Biochem. 259:426-434.
17. Devi, C. M., M. Y. Bai, A. V. Lal, P. R. Umashankar, and L. K. Krishnan. 2002. An improved method for isolation of anti-viper venom antibodies from chicken egg yolk. J. Biochem. Biophys. Methods 51:129-138.
18. Dyck, M. K., D. Lacroix, F. Pothier, and M. A. Sirard. 2003. Making recombinant proteins in animals - different systems, different applications. Trends Biotechnol. 21:394-399.
19. Ebina, T., A. Sato, K. Umezu, N. Ishida, S. Ohyama, A. Ohizumi, K. Aikawa, S. Katagiri, N. Katsushima, A. Imai, et al. 1983. Prevention of rotavirus infection by cow colostrum antibody against human rotaviruses. Lancet 2:1029-1030.
20. Ebina, T., A. Sato, K. Umezu, N. Ishida, S. Ohyama, A. Oizumi, K. Aikawa, S. Katagiri, N. Katsushima, A. Imai, et al. 1985. Prevention of rotavirus infection by oral administration of cow colostrum containing anti-humanrotavirus antibody. Med. Microbiol. Immunol. Berl. 174:177-185.
21. Ehrlich, P. 1892. Ueber Immunität durch Verebung und Zeugung. Z. Hyg. Infektionskr. 12:183-203.
22. Filler, S. J., R. L. Gregory, S. M. Michalek, J. Katz, and J. R. McGhee. 1991. Effect of immune bovine milk on Streptococcus mutans in human dental plaque. Arch. Oral Biol. 36:41-47.
23. Fischer, R., D. Schumann, S. Zimmermann, J. Drossard, M. Sack, and S. Schillberg. 1999. Expression and characterization of bispecific single-chain Fv fragments produced in transgenic plants. Eur. J. Biochem. 262:810-816.
24. Fischer, R., R. M. Twyman, and S. Schillberg. 2003. Production of antibodies in plants and their use for global health. Vaccine 21:820-825.
25. Freedman, D. J., C. O. Tacket, A. Delehanty, D. R. Maneval, J. Nataro, and J. H. Crabb. 1998. Milk immunoglobulin with specific activity against purified colonization factor antigens can protect against oral challenge with enterotoxigenic Escherichia coli. J. Infect. Dis. 177:662-667.
26. Grundbacher, F. J. 1992. Behring's discovery of diphtheria and tetanus antitoxins. Immunol. Today 13:188-190.
27. Hatta, H., M. Ozeki, and K. Tsuda. 1997a. Egg yolk antibody IgY and its application. Page 151-178 in Hen Eggs: Their Basic and Applied Science. T. Yamamoto, L. R. Juneja, H. Hatta, and M. Kim, ed. CRC Press, New York.
28. Hatta, H., K. Tsuda, M. Ozeki, M. Kim, T. Yamamoto, S. Otake, M. Hirasawa, J. Katz, N. K. Childers, and S. M. Michalek. 1997b. Passive immunization against dental plaque formation in humans: Effect of a mouth rinse containing egg yolk antibodies IgY specific to Streptococcus mutans. Caries Res. 31:268-274.
29. Hayden, M. S., L. K. Gilliland, and J. A. Ledbetter. 1997. Antibody engineering. Curr. Opin. Immunol. 9:201-212.
30. Hennig-Pauka, I., I. Stelljes, and K. H. Waldmann. 2003. Studies on the effect of specific egg antibodies against Escherichia coli infections in piglets. Dtsch. Tierarztl. Wochenschr. 110:49-54.
31. Henrichsen, J. 1999. Typing of Streptococcus pneumoniae: Past, present, and future. Am. J. Med. 107:50S-54S.
32. Hiatt, A., R. Cafferkey, and K. Bowdish. 1989. Production of antibodies in transgenic plants. Nature 342:76-78.
33. Hood, E. E., S. L. Woodard, and M. E. Horn. 2002. Monoclonal antibody manufacturing in transgenic plants - Myths and realities. Curr. Opin. Biotechnol. 13:630-635.
34. Huston, J. S., D. Levinson, M. Mudgett-Hunter, M. S. Tai, J. Novotny, M. N. Margolies, R. J. Ridge, R. E. Bruccoleri, E. Haber, R. Crea, et al. 1988. Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc. Natl. Acad. Sci. USA 85:5879-5883.
35. Ikemori, Y., M. Kuroki, R. C. Peralta, H. Yokoyama, and Y. Kodama. 1992. Protection of neonatal calves against fatal enteric colibacillosis by administration of egg yolk powder from hens immunized with K99-piliated enterotoxigenic Escherichia coli. Am. J. Vet. Res. 53:2005-2008.
36. Ikemori, Y., M. Ohta, K. Umeda, F. C. Icatlo, Jr., M. Kuroki, H. Yokoyama, and Y. Kodama. 1997. Passive protection of neonatal calves against bovine coronavirus-induced diarrhea by administration of egg yolk or colostrum antibody powder. Vet. Microbiol. 58:105-111.
37. Keller, M. A., and E. R. Stiehm. 2000. Passive immunity in prevention and treatment of infectious diseases. Clin. Microbiol. Rev. 13:602-614.
38. Kipriyanov, S. M., and F. Le Gall. 2004. Generation and production of engineered antibodies. Mol. Biotechnol. 26:39-60.
39. Korhonen, H., P. Marnila, and H. S. Gill. 2000a. Bovine milk antibodies for health. Br. J. Nutr. 84(Suppl. 1):S135-146.
40. Korhonen, H., P. Marnila, and H. S. Gill. 2000b. Milk immunoglobulins and complement factors. Br. J. Nutr. 84(Suppl. 1):S75-80.
41. Krause, R. M., N. J. Dimmock, and D. M. Morens. 1997. Summary of antibody workshop: The role of humoral immunity in the treatment and prevention of emerging and extant infectious diseases. J. Infect. Dis. 176:549-559.
42. Kuby, J. 1992. Immunoglobulins: Structure and function. Page 111 in Immunology. W. H. Freeman and Company, New York.
43. Kuroki, M., M. Ohta, Y. Ikemori, R. C. Peralta, H. Yokoyama, and Y. Kodama. 1994. Passive protection against bovine rotavirus in calves by specific immunoglobulins from chicken egg yolk. Arch. Virol. 138:143-148.
44. Ma, J. K., A. Hiatt, M. Hein, N. D. Vine, F. Wang, P. Stabila, C., van Dolleweerd, K. Mostov, and T. Lehner. 1995. Generation and assembly of secretory antibodies in plants. Science 268:716-719.
45. Marquardt, R. R., L. Z. Jin, J. W. Kim, L. Fang, A. A. Frohlich, and S. K. Baidoo. 1999. Passive protective effect of egg-yolk antibodies against enterotoxigenic Escherichia coli K88+ infection in neonatal and early-weaned piglets. FEMS Immunol. Med. Microbiol. 23:283-288.
46. Maya Devi, C., M. Vasantha Bai, and L. K. Krishnan. 2002. Development of viper-venom antibodies in chicken egg yolk and assay of their antigen binding capacity. Toxicon 40:857-861.
47. McCafferty, J., A. D. Griffiths, G. Winter, and D. J. Chiswell. 1990. Phage antibodies: Filamentous phage displaying antibody variable domains. Nature 348:552-554.
48. McFadden, T. B., T. E. Besser, and G. M. Barringon. 1997. Regulation of immunoglobulin transfer into mammary secretions of ruminants. Pages 133-152 in Milk, Composition, Production and Biotechnology. R. A. S. Welch, D. J. W. Burns, S. R. Davis, A. I. Popay, and C. G. Prosser, ed. CAB International, Wallingford, UK.
49. Mine, Y., and J. Kovacs-Nolan. 2002. Chicken egg yolk antibodies as therapeutics in enteric infectious disease: A review. J. Med. Food. 5:159-169.
50. Nagesha, H. S., L. F. Wang, B. Shiell, G. Beddome, J. R. White, and R. A. Irving. 2001. A single chain Fv antibody displayed on phage surface recognises conformational group-specific epitope of bluetongue virus. J. Virol. Methods 91:203-207.
51. Oral, H. B., C. Ozakin, and C. A. Akdis. 2002. Back to the future: Antibody-based strategies for the treatment of infectious diseases. Mol. Biotechnol. 21:225-239.
52. Owusu-Asiedu, A., C. M. Nyachoti, S. K. Baidoo, R. R. Marquardt, and X. Yang. 2003. Response of early-weaned pigs to an enterotoxigenic Escherichia coli K88 challenge when fed diets containing spray-dried porcine plasma or pea protein isolate plus egg yolk antibody. J. Anim. Sci. 81:1781-1789.
53. Pini, A., and L. Bracci. 2000. Phage display of antibody fragments. Curr. Protein Pept. Sci. 1:155-169.
54. Pluckthun, A. 1991. Antibody engineering. Curr. Opin. Biotechnol. 2:238-246.
55. Reilly, R. M., R. Domingo, and J. Sandhu. 1997. Oral delivery of antibodies. Future pharmacokinetic trends. Clin. Pharmacokinet. 32:313-323.
56. Rose, M. E., E. Orlans, and N. Buttress. 1974. Immunoglobulin classes in the hen's egg: Their segregation in yolk and white. Eur. J. Immunol. 4:521.
57. Shimamoto, C., S. Tokioka, I. Hirata, H. Tani, H. Ohishi, and K. Katsu. 2002. Inhibition of Helicobacter pylori infection by orally administered yolk-derived anti-Helicobacter pylori antibody. Hepatogastroenterology 49:709-714.
58. Shin, J. H., M. Yang, S. W. Nam, J. T. Kim, N. H. Myung, W. G. Bang, and I. H. Roe. 2002. Use of egg yolk-derived immunoglobulin as an alternative to antibiotic treatment for control of Helicobacter pylori infection. Clin. Diagn. Lab. Immunol. 9:1061-1066.
59. Stoger, E., C. Vaquero, E. Torres, M. Sack, L. Nicholson, J. Drossard, S. Williams, D. Keen, Y. Perrin, P. Christou, and R. Fischer. 2000. Cereal crops as viable production and storage systems for pharmaceutical scFv antibodies. Plant. Mol. Biol. 42:583-590.
60. Tacket, C. O., G. Losonsky, H. Link, Y. Hoang, P. Guesry, H. Hilpert, and M. M. Levine. 1988. Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli. N. Engl. J. Med. 318:1240-1243.
61. Thalley, B. S., and S. B. Carroll. 1990. Rattlesnake and scorpion antivenoms from the egg yolks of immunized hens. Biotechnology (N. Y.) 8:934-938.
62. Torres, E., C. Vaquero, L. Nicholson, M. Sack, E. Stoger, J. Drossard, P. Christou, R. Fischer, and Y. Perrin. 1999. Rice cell culture as an alternative production system for functional diagnostic and therapeutic antibodies. Transgenic Res. 8:441-449.
63. Van de Perre, P. 2003. Transfer of antibody via mother's milk. Vaccine 21:3374-3376.
64. Vaquero, C., M. Sack, J. Chandler, J. Drossard, F. Schuster, M. Monecke, S. Schillberg, and R. Fischer. 1999. Transient expression of a tumor-specific single-chain fragment and a chimeric antibody in tobacco leaves. Proc. Natl. Acad. Sci. USA 96:11128-11133.
65. Warzecha, H., and H. S. Mason. 2003. Benefits and risks of antibody and vaccine production in transgenic plants. J. Plant Physiol. 160:755-764.
66. Weisse, M. E. 2001. The fourth disease, 1900-2000. Lancet 357:299-301.
67. Winau, F., and R. Winau. 2002. Emil von Behring and serum therapy. Microbes Infect. 4:185-188.
68. Winter, G., A. D. Griffiths, R. E. Hawkins, and H. R. Hoogenboom. 1994. Making antibodies by phage display technology. Annu. Rev. Immunol. 12:433-455.
69. Yokoyama, H., R. C. Peralta, K. Umeda, T. Hashi, F. C. Icatlo, Jr., M. Kuroki, Y. Ikemori, and Y. Kodama. 1998. Prevention of fatal salmonellosis in neonatal calves, using orally administered chicken egg yolk Salmonella-specific antibodies. Am. J. Vet. Res. 59:416-420.